The Case for Psychedelics for Depression Is Getting Stronger
After Oregon legalizes psilocybin, a new study adds to a growing body of literature that psychedelics can be useful for psychiatry
Published in
Nov 18, 2020
As mental healthcare continues to be destigmatized, new treatments, including hallucinogenic mushrooms, provide therapeutic effects.
A new study offers more data showing that psychedelics can be useful for those experiencing depressive episodes. Smith notes:
“Researchers found that two separate doses of the psychedelic compound, combined with a total of 11 hours of therapy in the weeks before and after taking the drug, significantly reduced depression symptoms in 71% of people. More than half of the clinical trial participants (54%) were considered to be in remission for their depression four weeks after the treatment.”
Read Smith’s entire story below.
